SPEAKER

Einar Bjornsson, M.D., PhD

Professor and Chief of the Department of Internal Medicine The National University of Iceland

Einar S. Björnsson, M.D., PhD was born in Iceland in 1958. Dr. Björnsson studied psychology and philosophy at the University of Iceland for three years before he started studies in medicine. He finished medical school in 1989 at the same University and then moved to Sweden. Dr. Björnssonspent almost 20 years in Gothenburg Sweden and defended his PhD there in 1994. He then spent a post-doc in Ann Arbor Michigan 1996-1997. Dr. Björnsson was a senior registrar at the John Radcliffe hospital in Oxford UK in 2001. He was appointed a Professor of Gastroenterology and Hepatology in Gothenburg 2006. Dr. Björnsson moved to Iceland in 2009. Positions and Honors Current Position: 8/2016-present Professor and Chief, Department of Internal Medicine, The National University Hospital and the Medical faculty University of Iceland Postgraduate Training: 07/1989-07/1990 Intern in Internal Medicine and Surgery, Mora Hospital, Mora, Sweden 07/1990-12/1993 Resident in Internal Medicine, Sahlgrenska University Hospital, Gothenburg Sweden 01/1993-12/1995 Fellowship in Gastroenterology, Sahlgrenska University Hospital, Gothenburg Sweden 01/1996-07/2008 Specialist in Gastroenterology, Sahlgrenska University Hospital, Gothenburg Sweden 09/2008-7/2009 Sabbatical at the Mayo Clinic Mn working with Keith Lindor MD on liver projects 09/2009-07/2016 Chief of Gastroenterology and Hepatology the University Hospital of Iceland. 09/2014-5/2015 Sabbatical at the NIH, NIDDK working with Jay Hoofnagle MD on liver projects 08/2016-present Professor and Chief of Internal Medicine at the University Hospital in Iceland Contribution to Science After a post-doc stay at the University of Michigan in Ann Arbor, Dr. Björnsson started research in Hepatology with a special focus on cholestatic liver disease and drug-induced liver injury. He has been the supervisor of nine individuals who have defended a PhD thesis, five in Sweden and four in Iceland. Dr. Björnsson was an executive editor of the Scandinavian Journal of Gastroenterology from 2013-2019 and has been an associate editor in the Journal of Hepatology since 2019. Björnsson is the author of more than 300 publications and more than 25.000 citations according to Google Scholar.

Speaker Agenda

Also Available On Demand.

Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture with Dr. Einar Bjornsson, Professor and Chief of the Department of Internal Medicine at the National University of Iceland - Hepatotoxicity from Checkpoint Inhibitors, Biologicals, Small Molecules

10:30 am
 - 
11:00 am

Biologic drugs are commonly prescribed for autoimmune conditions and malignancies. How do we manage biologics’ effect on the liver? Acute liver failure has been reported in some patients on TNF-alpha inhibitors. Checkpoint inhibitors that modulate T-cell immune reactivity in cancer are frequently associated with liver injury. This session explores monitoring of liver tests, therapy cessation, corticosteroids and other hot topics.